Formulation and antitumor efficacy of liposomal-caprylated-TNF-Sam2

Cytokines and Molecular Therapy

Volumn 1, Issue 3, 1995, Pages 197-210

  Akimaru, K ^a   Auzenne, E ^a   Akimaru, Y ^a   Leroux, M E ^a   Hayman, A C ^a   Utsumi, T ^a   Soma, G I ^a   Klostergaard, J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; LIPOSOME; PEPTIDE FRAGMENT; PHOSPHATIDYLGLYCEROL; TNF SAM2; TNF-SAM2; TUMOR NECROSIS FACTOR;

ANIMAL; ARTICLE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; MOUSE STRAIN; SARCOMA;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DRUG CARRIERS; LIPOSOMES; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PHOSPHATIDYLGLYCEROLS; SARCOMA, EXPERIMENTAL; SPECTRUM ANALYSIS, MASS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0029360457     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)